GLYCODesign Inc. (GD) has entered into a joint venture with Leo Pharmaceutical Products Ltd. (Leo) of Denmark to develop novel drug candidates for the treatment of selected cardiovascular diseases. During the initial three-year term of the collaboration, GD and Leo will combine their respective strengths in cardiovascular research and the manufacture of drugs based on Read more about GLYCODesign And Leo Signs Cardiovascular Collaboration[…]